Vesicular carrier constructs for topical immunisation

Expert Opinion on Drug Delivery

Volumn 4, Issue 4, 2007, Pages 341-348

  Vyas, Suresh P ^a   Khatri, Kapil ^a   Mishra, Vivek ^b  

^a DR H S GOUR UNIVERSITY   (India)

^b ADINA Institute of Pharmaceutical Sciences   (India)

Author keywords

Liposomes; Niosomes; Topical immunisation; Transfersomes; Vesosomes

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; ADJUVANT; ALUMINUM POTASSIUM SULFATE; BOVINE SERUM ALBUMIN; CHOLERA TOXIN; CHOLESTEROL; CHOLIC ACID; DEOXYCHOLATE SODIUM; DNA VACCINE; DRUG CARRIER; DRUG VEHICLE; HEPATITIS B SURFACE ANTIGEN; LEUKOTOXIN; LIPID; LIPOSOME; MANNAN; NAKED DNA; NIOSOME; OCTADECYLAMINE; PHOSPHATIDYLCHOLINE; PLASMID DNA; PLASMID VECTOR; SORBITAN STEARATE; SORBITAN TRIOLEATE; TETANUS TOXOID; TRANSFERSOME; UNCLASSIFIED DRUG; UNINDEXED DRUG; VACCINE; VESOSOME; VIRUS GLYCOPROTEIN;

ANTIGEN PRESENTING CELL; CELLULAR IMMUNITY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOCOMPETENT CELL; MACROMOLECULE; NONHUMAN; REVIEW; SKIN; VACCINATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG COMPOUNDING; GENE TRANSFER TECHNIQUES; HUMANS; IMMUNIZATION; LIPOSOMES; NANOSTRUCTURES; SKIN; SKIN ABSORPTION; VACCINES;

EID: 34547908527     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.4.4.341     Document Type: Review

References (45)

1. GLENN GM, RAO M, MATYAS GR, ALVING CR: Skin immunization made possible by cholera toxin. Nature (1998) 391(6670):851.
2. STREILEIN JW: Skin-associated lymphoid tissues (SALT): origins and functions. J. Invest. Dermatol. (1983) 80(Suppl.):S12-S16.
3. BOS JD, KAPSENBERG ML: The skin immune system: progress in cutaneous biology. Immunol. Today (1993) 4(2):75-78.
4. +T cell responses: the alternative approaches. Ann. Rev. Immunol. (1997) 15:297-322.
5. LUBECK MD, STEPLEWSKI Z, BAGLIA F, KLEIN MH, DORRINGTON KJ, KOPROWSKI H: The interaction of murine IgG subclass proteins with human monocyte Fc receptors. J. Immunol. (1985) 135: 1299-1304.
6. GLENN GM, SCHARTON-KERSTEN T, VASSELL R, MALLETT CP, HALE TL, ALVING CR: Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge. J. Immunol. (1998) 161:3211-3214.
7. SCHARTON-KERSTEN T, YU J, VASSELL R, O'HAGAN D, ALVING CR, GLENN GM: Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants. Infect. Immunol. (2000) 68(9):5306-5313.
8. BIRBECK MS, BREATHNACH AS, EVERALL JD: An electron microscope study of basal melanocytes and high level clear cells (Langerhans cells) in vitiligo. J. Invest. Dermatol. (1961) 37:51-55.
9. ITOH T, CELIS EJ: Transcutaneous immunization with cytotoxic T-cell peptide epitopes provides effective antitumor immunity in mice. Immunotherapy (2005) 28(5):430-437.
10. WARGER T, RECHTSTEINER G, SCHMID B, OSTERLOH P, SCHILD H, RADSAK MP: Transcutaneous immunization with imiquimod is amplified by CD40 ligation and results in sustained cytotoxic T-lymphocyte activation and tumor protection. Clin. Rev. Allergy Immunol. (2007) 32(1):57-66.
11. MCALLISTER DV, WANG PM, DAVIS SP et al.: Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc. Natl. Acad. Sci. USA (2003) 100:13755-13760.
12. GIUDICE EL, CAMPBELL JD: Needle-free vaccine delivery. Adv. Drug Deliv. Rev. (2006) 58:68-89.
13. TANG DC, SHI Z, CURIEL DT: Vaccination onto bare skin. Nature (1997) 388:7290-730.
14. SHI Z, CURIEL DT, TANG DC: DNA based non-invasive vaccination onto the skin. Vaccine (1999) 17:2136-2141.
15. FAN H, LIN Q, MORRISSEY GR, KHAVARI PA: Immunization via hair follicles by topical application of naked DNA to normal skin. Nat. Biotechnol. (1999) 17:870-872.
16. SCHREIER H, BOUWSTRA JA: Liposomes and niosomes as drug carriers: dermal and transdermal drug delivery. J. Control. Release (1994) 30:1-15.
17. FANG JY, HONG CT, CHIU WT, WANG YY. Effect of liposomes and niosomes on skin permeation of enoxacin. Int. J. Pharm. (2001) 219:61-72.
18. BOUWSTRA JA, HONEYWELL-NGUYEN PL: Skin structure and mode of action of vesicles. Adv. Drug Deliv. Rev. (2002) 54:41-55.
19. + cytotoxic T lymphocytes. FEBS Lett. (1998) 441:353-356.
20. VAN BROEKHOVEN CL, PARISH CR, DEMANGEL C, BRITTON WJ, ALTIN JG: Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy. Cancer Res. (2004) 64:4357-4365.
21. GIESELER RK. MARQUITAN G, HAHN MJ et al.: Design-specific liposomal targeting and selective intracellular compound delivery to human myeloid dendritic cells: implications for HIV disease. Scand. J. Immunol. (2004) 59:415-424.
22. HATTORI Y, KAWAKAMI S, SUZUKI S, YAMASHITA F, HASHIDA M: Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice. Biochem. Biophys. Res. Commun. (2004) 317:992-999.
23. ARIGITA C, BEVAART L, EVERSE LA et al.: Liposomal meningococcal B vaccination: role of dendritic cell targeting in the development of a protective immune response. Infect. Immunol. (2003) 71:5210-5218.
24. MACHLUF M, APTE RN, REGEV O, COHEN S: Enhancing the immunogenicity of liposomal hepatitis B surface antigen (HBsAg) by controlling its delivery from polymeric microspheres. J. Pharm. Sci. (2000) 89(12):1550-1557.
25. WALKER SA, KENNEDY MT, ZASADZINSKI JA: Encapsulation of bilayer vesicles by self assembly. Nature (1997) 387:61-64.
26. MISHRA V, MAHOR S, RAWAT A et al.: Development of novel fusogenic vesosomes for transcutaneous immunization. Vaccine (2006) 24:5559-5570.
27. YOSHIOKA T, STENBERG B, FLORENCE AT: Preparation and properties of vesicles (niosomes) of sorbitan monoesters (span 20, 40, 60 and 80) and a sorbitan triester (span 85). Int. J. Pharm. (1994) 105:1-6.
28. UCHEGBU IF, VYAS SP: Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int. J. Pharm. (1998) 172:33-70.
29. VYAS SP, SINGH RP, JAIN S et al.: Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. Int. J. Pharm. (2005) 296:80-86.
30. JAIN S, VYAS SP: Mannosylated niosomes as carrier adjuvant system for topical immunization. J. Pharm. Pharmacol. (2005) 57(9):1177-1184.
31. KERY V, KREPINSKY JJ, WARREN CD, CAPEK P, STAHL PD: Ligand recognition by purified human mannose receptor. Arch. Biochem. Biophys. (1992) 298:49-55.
32. GARCON N, GREGORIADIS G, TAYLOR M, SUMMERFIELD J: Mannose-mediated targeted immunoadjuvant action of liposomes. Immunology (1988) 64:743-754.
33. VALJAKKA-KOSKELA R, KIRJAVAINEN M, MONKKONEN J, URTTI A, KIESVAARA J: Enhancement of percutaneous absorption of naproxen by phospholipids. Int. J. Pharm. (1998) 175:225-230.
34. VALENTA C, WANKA M, HEIDLAS J: Evaluation of novel soya lecithin formulations for dermal use ontainingketoprofen as a model drug. J. Control. Release (2000) 63:165-173.
35. CEVC G, BLUME G: Lipid vesicles penetrate into intact skin owing to the transepidermal osmotic gradients and hydration force. Biochim. Biophys. Acta (1992) 1104:226-232.
36. CEVC G, BLUME G, SCHATZLEIN A, GEBAUER D: The skin: a pathway for the systemic treatment with patches and lipid-based agent carriers. Adv. Drug Deliv. Rev. (1996) 18:349-378.
37. CEVC G, SCHATZLEIN A, BLUME G: Transdermal drug carriers: basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides. J. Control. Release (1995) 36:3-16.
38. PAUL A, CEVC G, BACHHAWAT BK: Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes. Vaccine (1998) 16(2-3):188-195.
39. GUPTA PN, MISHRA V, SINGH P et al.: Tetanus toxoid loaded transferosomes for topical immunization. J. Pharm. Pharmacol. (2005) 57:1-7.
40. GUPTA PN, MISHRA V, RAWAT A et al.: Noninvasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. Int. J. Pharm. (2005) 293:73-82.
41. KIM A, LEE EH, CHOI S, KIM C: In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome. Biomaterials (2004) 25:305-313.
42. MAHOR S, RAWAT A, DUBEY PK et al.: Cationic transfersomes based topical genetic vaccine against hepatitis B. Int. J. Pharm. (2007) (In Press).
43. LIANG R, ZHUANG F, MENG Z, DENG M, ZHENG C, DUAN M: A new potent route of DNA vaccine inoculation: DNA-liposome complexes on bare skin induce antigen-special antibody responses. Molecules (2003) 8:120-126.
44. BACA-ESTRADA ME, FOLDVARI M, EWEN C, BADEA I, BABIUK LA: Effects of IL-12 on immune responses induced by transcutaneous immunization with antigens formulated in a novel lipid-based biphasic delivery system. Vaccine (2000) 18(17):1847-1854.
45. BABIUK S, BACA-ESTRADA ME, PONTAROLLO R, FOLDVARI M: Topical delivery of plasmid DNA using biphasic lipid vesicles (Biphasix). J. Pharm. Pharmacol. (2002) 54(12):1609-1614.